Global Malaria Vaccines Market Research Report 2026(Status and Outlook)
Malaria Vaccines are used for malaria treatment. Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Malaria Vaccines market size was estimated at USD 2335.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Malaria Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Malaria Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Malaria Vaccines market.
Global Malaria Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline Plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec
Actiza Pharmaceutical Private Limited
AdvaCare Pharma
Ipca Laboratories Ltd
Bliss GVS Pharma Ltd
GeoVax
Pfizer Inc
VLP Therapeutics
OSIVAX
AJANTA PHARMA
Strides Pharma Science Limited
Mylan N.V.
Zydus Cadila
Cipla Inc
Sun Pharmaceutical Industries Ltd
Sanofi
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals LLC
Taj Pharmaceuticals Limited
Lupin
Novartis AG
CellFree Sciences
Market Segmentation (by Type)
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine
Market Segmentation (by Application)
Hospitals
Clinics
Community Centers
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Malaria Vaccines Market
Overview of the regional outlook of the Malaria Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Malaria Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Malaria Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Malaria Vaccines market size was estimated at USD 2335.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Malaria Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Malaria Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Malaria Vaccines market.
Global Malaria Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline Plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec
Actiza Pharmaceutical Private Limited
AdvaCare Pharma
Ipca Laboratories Ltd
Bliss GVS Pharma Ltd
GeoVax
Pfizer Inc
VLP Therapeutics
OSIVAX
AJANTA PHARMA
Strides Pharma Science Limited
Mylan N.V.
Zydus Cadila
Cipla Inc
Sun Pharmaceutical Industries Ltd
Sanofi
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals LLC
Taj Pharmaceuticals Limited
Lupin
Novartis AG
CellFree Sciences
Market Segmentation (by Type)
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine
Market Segmentation (by Application)
Hospitals
Clinics
Community Centers
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Malaria Vaccines Market
Overview of the regional outlook of the Malaria Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Malaria Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Malaria Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Malaria Vaccines
1.2 Key Market Segments
1.2.1 Malaria Vaccines Segment by Type
1.2.2 Malaria Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MALARIA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Malaria Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Malaria Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MALARIA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Malaria Vaccines Product Life Cycle
3.3 Global Malaria Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Malaria Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Malaria Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Malaria Vaccines Market Competitive Situation and Trends
3.8.1 Malaria Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Malaria Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MALARIA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Malaria Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MALARIA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Malaria Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Malaria Vaccines Market
5.7 ESG Ratings of Leading Companies
6 MALARIA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Malaria Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Malaria Vaccines Market Size by Type (2020-2025)
6.4 Global Malaria Vaccines Price by Type (2020-2025)
7 MALARIA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Malaria Vaccines Market Sales by Application (2020-2025)
7.3 Global Malaria Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Malaria Vaccines Sales Growth Rate by Application (2020-2025)
8 MALARIA VACCINES MARKET SALES BY REGION
8.1 Global Malaria Vaccines Sales by Region
8.1.1 Global Malaria Vaccines Sales by Region
8.1.2 Global Malaria Vaccines Sales Market Share by Region
8.2 Global Malaria Vaccines Market Size by Region
8.2.1 Global Malaria Vaccines Market Size by Region
8.2.2 Global Malaria Vaccines Market Size by Region
8.3 North America
8.3.1 North America Malaria Vaccines Sales by Country
8.3.2 North America Malaria Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Malaria Vaccines Sales by Country
8.4.2 Europe Malaria Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Malaria Vaccines Sales by Region
8.5.2 Asia Pacific Malaria Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Malaria Vaccines Sales by Country
8.6.2 South America Malaria Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Malaria Vaccines Sales by Region
8.7.2 Middle East and Africa Malaria Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MALARIA VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Malaria Vaccines by Region(2020-2025)
9.2 Global Malaria Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Malaria Vaccines Production
9.4.1 North America Malaria Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Malaria Vaccines Production
9.5.1 Europe Malaria Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Malaria Vaccines Production (2020-2025)
9.6.1 Japan Malaria Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Malaria Vaccines Production (2020-2025)
9.7.1 China Malaria Vaccines Production Growth Rate (2020-2025)
9.7.2 China Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline Plc
10.1.1 GlaxoSmithKline Plc Basic Information
10.1.2 GlaxoSmithKline Plc Malaria Vaccines Product Overview
10.1.3 GlaxoSmithKline Plc Malaria Vaccines Product Market Performance
10.1.4 GlaxoSmithKline Plc Business Overview
10.1.5 GlaxoSmithKline Plc SWOT Analysis
10.1.6 GlaxoSmithKline Plc Recent Developments
10.2 Sanaria Inc
10.2.1 Sanaria Inc Basic Information
10.2.2 Sanaria Inc Malaria Vaccines Product Overview
10.2.3 Sanaria Inc Malaria Vaccines Product Market Performance
10.2.4 Sanaria Inc Business Overview
10.2.5 Sanaria Inc SWOT Analysis
10.2.6 Sanaria Inc Recent Developments
10.3 Nobelpharma Co
10.3.1 Nobelpharma Co Basic Information
10.3.2 Nobelpharma Co Malaria Vaccines Product Overview
10.3.3 Nobelpharma Co Malaria Vaccines Product Market Performance
10.3.4 Nobelpharma Co Business Overview
10.3.5 Nobelpharma Co SWOT Analysis
10.3.6 Nobelpharma Co Recent Developments
10.4 Sumaya Biotech
10.4.1 Sumaya Biotech Basic Information
10.4.2 Sumaya Biotech Malaria Vaccines Product Overview
10.4.3 Sumaya Biotech Malaria Vaccines Product Market Performance
10.4.4 Sumaya Biotech Business Overview
10.4.5 Sumaya Biotech Recent Developments
10.5 GenVec
10.5.1 GenVec Basic Information
10.5.2 GenVec Malaria Vaccines Product Overview
10.5.3 GenVec Malaria Vaccines Product Market Performance
10.5.4 GenVec Business Overview
10.5.5 GenVec Recent Developments
10.6 Actiza Pharmaceutical Private Limited
10.6.1 Actiza Pharmaceutical Private Limited Basic Information
10.6.2 Actiza Pharmaceutical Private Limited Malaria Vaccines Product Overview
10.6.3 Actiza Pharmaceutical Private Limited Malaria Vaccines Product Market Performance
10.6.4 Actiza Pharmaceutical Private Limited Business Overview
10.6.5 Actiza Pharmaceutical Private Limited Recent Developments
10.7 AdvaCare Pharma
10.7.1 AdvaCare Pharma Basic Information
10.7.2 AdvaCare Pharma Malaria Vaccines Product Overview
10.7.3 AdvaCare Pharma Malaria Vaccines Product Market Performance
10.7.4 AdvaCare Pharma Business Overview
10.7.5 AdvaCare Pharma Recent Developments
10.8 Ipca Laboratories Ltd
10.8.1 Ipca Laboratories Ltd Basic Information
10.8.2 Ipca Laboratories Ltd Malaria Vaccines Product Overview
10.8.3 Ipca Laboratories Ltd Malaria Vaccines Product Market Performance
10.8.4 Ipca Laboratories Ltd Business Overview
10.8.5 Ipca Laboratories Ltd Recent Developments
10.9 Bliss GVS Pharma Ltd
10.9.1 Bliss GVS Pharma Ltd Basic Information
10.9.2 Bliss GVS Pharma Ltd Malaria Vaccines Product Overview
10.9.3 Bliss GVS Pharma Ltd Malaria Vaccines Product Market Performance
10.9.4 Bliss GVS Pharma Ltd Business Overview
10.9.5 Bliss GVS Pharma Ltd Recent Developments
10.10 GeoVax
10.10.1 GeoVax Basic Information
10.10.2 GeoVax Malaria Vaccines Product Overview
10.10.3 GeoVax Malaria Vaccines Product Market Performance
10.10.4 GeoVax Business Overview
10.10.5 GeoVax Recent Developments
10.11 Pfizer Inc
10.11.1 Pfizer Inc Basic Information
10.11.2 Pfizer Inc Malaria Vaccines Product Overview
10.11.3 Pfizer Inc Malaria Vaccines Product Market Performance
10.11.4 Pfizer Inc Business Overview
10.11.5 Pfizer Inc Recent Developments
10.12 VLP Therapeutics
10.12.1 VLP Therapeutics Basic Information
10.12.2 VLP Therapeutics Malaria Vaccines Product Overview
10.12.3 VLP Therapeutics Malaria Vaccines Product Market Performance
10.12.4 VLP Therapeutics Business Overview
10.12.5 VLP Therapeutics Recent Developments
10.13 OSIVAX
10.13.1 OSIVAX Basic Information
10.13.2 OSIVAX Malaria Vaccines Product Overview
10.13.3 OSIVAX Malaria Vaccines Product Market Performance
10.13.4 OSIVAX Business Overview
10.13.5 OSIVAX Recent Developments
10.14 AJANTA PHARMA
10.14.1 AJANTA PHARMA Basic Information
10.14.2 AJANTA PHARMA Malaria Vaccines Product Overview
10.14.3 AJANTA PHARMA Malaria Vaccines Product Market Performance
10.14.4 AJANTA PHARMA Business Overview
10.14.5 AJANTA PHARMA Recent Developments
10.15 Strides Pharma Science Limited
10.15.1 Strides Pharma Science Limited Basic Information
10.15.2 Strides Pharma Science Limited Malaria Vaccines Product Overview
10.15.3 Strides Pharma Science Limited Malaria Vaccines Product Market Performance
10.15.4 Strides Pharma Science Limited Business Overview
10.15.5 Strides Pharma Science Limited Recent Developments
10.16 Mylan N.V.
10.16.1 Mylan N.V. Basic Information
10.16.2 Mylan N.V. Malaria Vaccines Product Overview
10.16.3 Mylan N.V. Malaria Vaccines Product Market Performance
10.16.4 Mylan N.V. Business Overview
10.16.5 Mylan N.V. Recent Developments
10.17 Zydus Cadila
10.17.1 Zydus Cadila Basic Information
10.17.2 Zydus Cadila Malaria Vaccines Product Overview
10.17.3 Zydus Cadila Malaria Vaccines Product Market Performance
10.17.4 Zydus Cadila Business Overview
10.17.5 Zydus Cadila Recent Developments
10.18 Cipla Inc
10.18.1 Cipla Inc Basic Information
10.18.2 Cipla Inc Malaria Vaccines Product Overview
10.18.3 Cipla Inc Malaria Vaccines Product Market Performance
10.18.4 Cipla Inc Business Overview
10.18.5 Cipla Inc Recent Developments
10.19 Sun Pharmaceutical Industries Ltd
10.19.1 Sun Pharmaceutical Industries Ltd Basic Information
10.19.2 Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Overview
10.19.3 Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Market Performance
10.19.4 Sun Pharmaceutical Industries Ltd Business Overview
10.19.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.20 Sanofi
10.20.1 Sanofi Basic Information
10.20.2 Sanofi Malaria Vaccines Product Overview
10.20.3 Sanofi Malaria Vaccines Product Market Performance
10.20.4 Sanofi Business Overview
10.20.5 Sanofi Recent Developments
10.21 Hikma Pharmaceuticals PLC
10.21.1 Hikma Pharmaceuticals PLC Basic Information
10.21.2 Hikma Pharmaceuticals PLC Malaria Vaccines Product Overview
10.21.3 Hikma Pharmaceuticals PLC Malaria Vaccines Product Market Performance
10.21.4 Hikma Pharmaceuticals PLC Business Overview
10.21.5 Hikma Pharmaceuticals PLC Recent Developments
10.22 Amneal Pharmaceuticals LLC
10.22.1 Amneal Pharmaceuticals LLC Basic Information
10.22.2 Amneal Pharmaceuticals LLC Malaria Vaccines Product Overview
10.22.3 Amneal Pharmaceuticals LLC Malaria Vaccines Product Market Performance
10.22.4 Amneal Pharmaceuticals LLC Business Overview
10.22.5 Amneal Pharmaceuticals LLC Recent Developments
10.23 Taj Pharmaceuticals Limited
10.23.1 Taj Pharmaceuticals Limited Basic Information
10.23.2 Taj Pharmaceuticals Limited Malaria Vaccines Product Overview
10.23.3 Taj Pharmaceuticals Limited Malaria Vaccines Product Market Performance
10.23.4 Taj Pharmaceuticals Limited Business Overview
10.23.5 Taj Pharmaceuticals Limited Recent Developments
10.24 Lupin
10.24.1 Lupin Basic Information
10.24.2 Lupin Malaria Vaccines Product Overview
10.24.3 Lupin Malaria Vaccines Product Market Performance
10.24.4 Lupin Business Overview
10.24.5 Lupin Recent Developments
10.25 Novartis AG
10.25.1 Novartis AG Basic Information
10.25.2 Novartis AG Malaria Vaccines Product Overview
10.25.3 Novartis AG Malaria Vaccines Product Market Performance
10.25.4 Novartis AG Business Overview
10.25.5 Novartis AG Recent Developments
10.26 CellFree Sciences
10.26.1 CellFree Sciences Basic Information
10.26.2 CellFree Sciences Malaria Vaccines Product Overview
10.26.3 CellFree Sciences Malaria Vaccines Product Market Performance
10.26.4 CellFree Sciences Business Overview
10.26.5 CellFree Sciences Recent Developments
11 MALARIA VACCINES MARKET FORECAST BY REGION
11.1 Global Malaria Vaccines Market Size Forecast
11.2 Global Malaria Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Malaria Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Malaria Vaccines Market Size Forecast by Region
11.2.4 South America Malaria Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Malaria Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Malaria Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Malaria Vaccines by Type (2026-2035)
12.1.2 Global Malaria Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Malaria Vaccines by Type (2026-2035)
12.2 Global Malaria Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Malaria Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Malaria Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Malaria Vaccines
1.2 Key Market Segments
1.2.1 Malaria Vaccines Segment by Type
1.2.2 Malaria Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MALARIA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Malaria Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Malaria Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MALARIA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Malaria Vaccines Product Life Cycle
3.3 Global Malaria Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Malaria Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Malaria Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Malaria Vaccines Market Competitive Situation and Trends
3.8.1 Malaria Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Malaria Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MALARIA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Malaria Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MALARIA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Malaria Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Malaria Vaccines Market
5.7 ESG Ratings of Leading Companies
6 MALARIA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Malaria Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Malaria Vaccines Market Size by Type (2020-2025)
6.4 Global Malaria Vaccines Price by Type (2020-2025)
7 MALARIA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Malaria Vaccines Market Sales by Application (2020-2025)
7.3 Global Malaria Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Malaria Vaccines Sales Growth Rate by Application (2020-2025)
8 MALARIA VACCINES MARKET SALES BY REGION
8.1 Global Malaria Vaccines Sales by Region
8.1.1 Global Malaria Vaccines Sales by Region
8.1.2 Global Malaria Vaccines Sales Market Share by Region
8.2 Global Malaria Vaccines Market Size by Region
8.2.1 Global Malaria Vaccines Market Size by Region
8.2.2 Global Malaria Vaccines Market Size by Region
8.3 North America
8.3.1 North America Malaria Vaccines Sales by Country
8.3.2 North America Malaria Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Malaria Vaccines Sales by Country
8.4.2 Europe Malaria Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Malaria Vaccines Sales by Region
8.5.2 Asia Pacific Malaria Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Malaria Vaccines Sales by Country
8.6.2 South America Malaria Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Malaria Vaccines Sales by Region
8.7.2 Middle East and Africa Malaria Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MALARIA VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Malaria Vaccines by Region(2020-2025)
9.2 Global Malaria Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Malaria Vaccines Production
9.4.1 North America Malaria Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Malaria Vaccines Production
9.5.1 Europe Malaria Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Malaria Vaccines Production (2020-2025)
9.6.1 Japan Malaria Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Malaria Vaccines Production (2020-2025)
9.7.1 China Malaria Vaccines Production Growth Rate (2020-2025)
9.7.2 China Malaria Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline Plc
10.1.1 GlaxoSmithKline Plc Basic Information
10.1.2 GlaxoSmithKline Plc Malaria Vaccines Product Overview
10.1.3 GlaxoSmithKline Plc Malaria Vaccines Product Market Performance
10.1.4 GlaxoSmithKline Plc Business Overview
10.1.5 GlaxoSmithKline Plc SWOT Analysis
10.1.6 GlaxoSmithKline Plc Recent Developments
10.2 Sanaria Inc
10.2.1 Sanaria Inc Basic Information
10.2.2 Sanaria Inc Malaria Vaccines Product Overview
10.2.3 Sanaria Inc Malaria Vaccines Product Market Performance
10.2.4 Sanaria Inc Business Overview
10.2.5 Sanaria Inc SWOT Analysis
10.2.6 Sanaria Inc Recent Developments
10.3 Nobelpharma Co
10.3.1 Nobelpharma Co Basic Information
10.3.2 Nobelpharma Co Malaria Vaccines Product Overview
10.3.3 Nobelpharma Co Malaria Vaccines Product Market Performance
10.3.4 Nobelpharma Co Business Overview
10.3.5 Nobelpharma Co SWOT Analysis
10.3.6 Nobelpharma Co Recent Developments
10.4 Sumaya Biotech
10.4.1 Sumaya Biotech Basic Information
10.4.2 Sumaya Biotech Malaria Vaccines Product Overview
10.4.3 Sumaya Biotech Malaria Vaccines Product Market Performance
10.4.4 Sumaya Biotech Business Overview
10.4.5 Sumaya Biotech Recent Developments
10.5 GenVec
10.5.1 GenVec Basic Information
10.5.2 GenVec Malaria Vaccines Product Overview
10.5.3 GenVec Malaria Vaccines Product Market Performance
10.5.4 GenVec Business Overview
10.5.5 GenVec Recent Developments
10.6 Actiza Pharmaceutical Private Limited
10.6.1 Actiza Pharmaceutical Private Limited Basic Information
10.6.2 Actiza Pharmaceutical Private Limited Malaria Vaccines Product Overview
10.6.3 Actiza Pharmaceutical Private Limited Malaria Vaccines Product Market Performance
10.6.4 Actiza Pharmaceutical Private Limited Business Overview
10.6.5 Actiza Pharmaceutical Private Limited Recent Developments
10.7 AdvaCare Pharma
10.7.1 AdvaCare Pharma Basic Information
10.7.2 AdvaCare Pharma Malaria Vaccines Product Overview
10.7.3 AdvaCare Pharma Malaria Vaccines Product Market Performance
10.7.4 AdvaCare Pharma Business Overview
10.7.5 AdvaCare Pharma Recent Developments
10.8 Ipca Laboratories Ltd
10.8.1 Ipca Laboratories Ltd Basic Information
10.8.2 Ipca Laboratories Ltd Malaria Vaccines Product Overview
10.8.3 Ipca Laboratories Ltd Malaria Vaccines Product Market Performance
10.8.4 Ipca Laboratories Ltd Business Overview
10.8.5 Ipca Laboratories Ltd Recent Developments
10.9 Bliss GVS Pharma Ltd
10.9.1 Bliss GVS Pharma Ltd Basic Information
10.9.2 Bliss GVS Pharma Ltd Malaria Vaccines Product Overview
10.9.3 Bliss GVS Pharma Ltd Malaria Vaccines Product Market Performance
10.9.4 Bliss GVS Pharma Ltd Business Overview
10.9.5 Bliss GVS Pharma Ltd Recent Developments
10.10 GeoVax
10.10.1 GeoVax Basic Information
10.10.2 GeoVax Malaria Vaccines Product Overview
10.10.3 GeoVax Malaria Vaccines Product Market Performance
10.10.4 GeoVax Business Overview
10.10.5 GeoVax Recent Developments
10.11 Pfizer Inc
10.11.1 Pfizer Inc Basic Information
10.11.2 Pfizer Inc Malaria Vaccines Product Overview
10.11.3 Pfizer Inc Malaria Vaccines Product Market Performance
10.11.4 Pfizer Inc Business Overview
10.11.5 Pfizer Inc Recent Developments
10.12 VLP Therapeutics
10.12.1 VLP Therapeutics Basic Information
10.12.2 VLP Therapeutics Malaria Vaccines Product Overview
10.12.3 VLP Therapeutics Malaria Vaccines Product Market Performance
10.12.4 VLP Therapeutics Business Overview
10.12.5 VLP Therapeutics Recent Developments
10.13 OSIVAX
10.13.1 OSIVAX Basic Information
10.13.2 OSIVAX Malaria Vaccines Product Overview
10.13.3 OSIVAX Malaria Vaccines Product Market Performance
10.13.4 OSIVAX Business Overview
10.13.5 OSIVAX Recent Developments
10.14 AJANTA PHARMA
10.14.1 AJANTA PHARMA Basic Information
10.14.2 AJANTA PHARMA Malaria Vaccines Product Overview
10.14.3 AJANTA PHARMA Malaria Vaccines Product Market Performance
10.14.4 AJANTA PHARMA Business Overview
10.14.5 AJANTA PHARMA Recent Developments
10.15 Strides Pharma Science Limited
10.15.1 Strides Pharma Science Limited Basic Information
10.15.2 Strides Pharma Science Limited Malaria Vaccines Product Overview
10.15.3 Strides Pharma Science Limited Malaria Vaccines Product Market Performance
10.15.4 Strides Pharma Science Limited Business Overview
10.15.5 Strides Pharma Science Limited Recent Developments
10.16 Mylan N.V.
10.16.1 Mylan N.V. Basic Information
10.16.2 Mylan N.V. Malaria Vaccines Product Overview
10.16.3 Mylan N.V. Malaria Vaccines Product Market Performance
10.16.4 Mylan N.V. Business Overview
10.16.5 Mylan N.V. Recent Developments
10.17 Zydus Cadila
10.17.1 Zydus Cadila Basic Information
10.17.2 Zydus Cadila Malaria Vaccines Product Overview
10.17.3 Zydus Cadila Malaria Vaccines Product Market Performance
10.17.4 Zydus Cadila Business Overview
10.17.5 Zydus Cadila Recent Developments
10.18 Cipla Inc
10.18.1 Cipla Inc Basic Information
10.18.2 Cipla Inc Malaria Vaccines Product Overview
10.18.3 Cipla Inc Malaria Vaccines Product Market Performance
10.18.4 Cipla Inc Business Overview
10.18.5 Cipla Inc Recent Developments
10.19 Sun Pharmaceutical Industries Ltd
10.19.1 Sun Pharmaceutical Industries Ltd Basic Information
10.19.2 Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Overview
10.19.3 Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Market Performance
10.19.4 Sun Pharmaceutical Industries Ltd Business Overview
10.19.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.20 Sanofi
10.20.1 Sanofi Basic Information
10.20.2 Sanofi Malaria Vaccines Product Overview
10.20.3 Sanofi Malaria Vaccines Product Market Performance
10.20.4 Sanofi Business Overview
10.20.5 Sanofi Recent Developments
10.21 Hikma Pharmaceuticals PLC
10.21.1 Hikma Pharmaceuticals PLC Basic Information
10.21.2 Hikma Pharmaceuticals PLC Malaria Vaccines Product Overview
10.21.3 Hikma Pharmaceuticals PLC Malaria Vaccines Product Market Performance
10.21.4 Hikma Pharmaceuticals PLC Business Overview
10.21.5 Hikma Pharmaceuticals PLC Recent Developments
10.22 Amneal Pharmaceuticals LLC
10.22.1 Amneal Pharmaceuticals LLC Basic Information
10.22.2 Amneal Pharmaceuticals LLC Malaria Vaccines Product Overview
10.22.3 Amneal Pharmaceuticals LLC Malaria Vaccines Product Market Performance
10.22.4 Amneal Pharmaceuticals LLC Business Overview
10.22.5 Amneal Pharmaceuticals LLC Recent Developments
10.23 Taj Pharmaceuticals Limited
10.23.1 Taj Pharmaceuticals Limited Basic Information
10.23.2 Taj Pharmaceuticals Limited Malaria Vaccines Product Overview
10.23.3 Taj Pharmaceuticals Limited Malaria Vaccines Product Market Performance
10.23.4 Taj Pharmaceuticals Limited Business Overview
10.23.5 Taj Pharmaceuticals Limited Recent Developments
10.24 Lupin
10.24.1 Lupin Basic Information
10.24.2 Lupin Malaria Vaccines Product Overview
10.24.3 Lupin Malaria Vaccines Product Market Performance
10.24.4 Lupin Business Overview
10.24.5 Lupin Recent Developments
10.25 Novartis AG
10.25.1 Novartis AG Basic Information
10.25.2 Novartis AG Malaria Vaccines Product Overview
10.25.3 Novartis AG Malaria Vaccines Product Market Performance
10.25.4 Novartis AG Business Overview
10.25.5 Novartis AG Recent Developments
10.26 CellFree Sciences
10.26.1 CellFree Sciences Basic Information
10.26.2 CellFree Sciences Malaria Vaccines Product Overview
10.26.3 CellFree Sciences Malaria Vaccines Product Market Performance
10.26.4 CellFree Sciences Business Overview
10.26.5 CellFree Sciences Recent Developments
11 MALARIA VACCINES MARKET FORECAST BY REGION
11.1 Global Malaria Vaccines Market Size Forecast
11.2 Global Malaria Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Malaria Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Malaria Vaccines Market Size Forecast by Region
11.2.4 South America Malaria Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Malaria Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Malaria Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Malaria Vaccines by Type (2026-2035)
12.1.2 Global Malaria Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Malaria Vaccines by Type (2026-2035)
12.2 Global Malaria Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Malaria Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Malaria Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Malaria Vaccines Market Size by Type (M USD)
Table 4. Global Malaria Vaccines Market Size by Application
Table 5. Malaria Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Malaria Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Malaria Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Malaria Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Malaria Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2025)
Table 11. Global Market Malaria Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Malaria Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Malaria Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Malaria Vaccines Sales by Type (K MT)
Table 27. Global Malaria Vaccines Market Size by Type (M USD)
Table 28. Global Malaria Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Malaria Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Malaria Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Malaria Vaccines Market Share by Type (2020-2025)
Table 32. Global Malaria Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Malaria Vaccines Sales (K MT) by Application
Table 34. Global Malaria Vaccines Market Size by Application
Table 35. Global Malaria Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Malaria Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Malaria Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Malaria Vaccines Market Share by Application (2020-2025)
Table 39. Global Malaria Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Malaria Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Malaria Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Malaria Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Malaria Vaccines Market Size by Region (2020-2025)
Table 44. North America Malaria Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Malaria Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Malaria Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Malaria Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Malaria Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Malaria Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Malaria Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Malaria Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Malaria Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Malaria Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Malaria Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Malaria Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Malaria Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GlaxoSmithKline Plc Basic Information
Table 63. GlaxoSmithKline Plc Malaria Vaccines Product Overview
Table 64. GlaxoSmithKline Plc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GlaxoSmithKline Plc Business Overview
Table 66. GlaxoSmithKline Plc SWOT Analysis
Table 67. GlaxoSmithKline Plc Recent Developments
Table 68. Sanaria Inc Basic Information
Table 69. Sanaria Inc Malaria Vaccines Product Overview
Table 70. Sanaria Inc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Sanaria Inc Business Overview
Table 72. Sanaria Inc SWOT Analysis
Table 73. Sanaria Inc Recent Developments
Table 74. Nobelpharma Co Basic Information
Table 75. Nobelpharma Co Malaria Vaccines Product Overview
Table 76. Nobelpharma Co Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Nobelpharma Co Business Overview
Table 78. Nobelpharma Co SWOT Analysis
Table 79. Nobelpharma Co Recent Developments
Table 80. Sumaya Biotech Basic Information
Table 81. Sumaya Biotech Malaria Vaccines Product Overview
Table 82. Sumaya Biotech Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sumaya Biotech Business Overview
Table 84. Sumaya Biotech Recent Developments
Table 85. GenVec Basic Information
Table 86. GenVec Malaria Vaccines Product Overview
Table 87. GenVec Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. GenVec Business Overview
Table 89. GenVec Recent Developments
Table 90. Actiza Pharmaceutical Private Limited Basic Information
Table 91. Actiza Pharmaceutical Private Limited Malaria Vaccines Product Overview
Table 92. Actiza Pharmaceutical Private Limited Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Actiza Pharmaceutical Private Limited Business Overview
Table 94. Actiza Pharmaceutical Private Limited Recent Developments
Table 95. AdvaCare Pharma Basic Information
Table 96. AdvaCare Pharma Malaria Vaccines Product Overview
Table 97. AdvaCare Pharma Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. AdvaCare Pharma Business Overview
Table 99. AdvaCare Pharma Recent Developments
Table 100. Ipca Laboratories Ltd Basic Information
Table 101. Ipca Laboratories Ltd Malaria Vaccines Product Overview
Table 102. Ipca Laboratories Ltd Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Ipca Laboratories Ltd Business Overview
Table 104. Ipca Laboratories Ltd Recent Developments
Table 105. Bliss GVS Pharma Ltd Basic Information
Table 106. Bliss GVS Pharma Ltd Malaria Vaccines Product Overview
Table 107. Bliss GVS Pharma Ltd Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Bliss GVS Pharma Ltd Business Overview
Table 109. Bliss GVS Pharma Ltd Recent Developments
Table 110. GeoVax Basic Information
Table 111. GeoVax Malaria Vaccines Product Overview
Table 112. GeoVax Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. GeoVax Business Overview
Table 114. GeoVax Recent Developments
Table 115. Pfizer Inc Basic Information
Table 116. Pfizer Inc Malaria Vaccines Product Overview
Table 117. Pfizer Inc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Pfizer Inc Business Overview
Table 119. Pfizer Inc Recent Developments
Table 120. VLP Therapeutics Basic Information
Table 121. VLP Therapeutics Malaria Vaccines Product Overview
Table 122. VLP Therapeutics Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. VLP Therapeutics Business Overview
Table 124. VLP Therapeutics Recent Developments
Table 125. OSIVAX Basic Information
Table 126. OSIVAX Malaria Vaccines Product Overview
Table 127. OSIVAX Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. OSIVAX Business Overview
Table 129. OSIVAX Recent Developments
Table 130. AJANTA PHARMA Basic Information
Table 131. AJANTA PHARMA Malaria Vaccines Product Overview
Table 132. AJANTA PHARMA Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. AJANTA PHARMA Business Overview
Table 134. AJANTA PHARMA Recent Developments
Table 135. Strides Pharma Science Limited Basic Information
Table 136. Strides Pharma Science Limited Malaria Vaccines Product Overview
Table 137. Strides Pharma Science Limited Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Strides Pharma Science Limited Business Overview
Table 139. Strides Pharma Science Limited Recent Developments
Table 140. Mylan N.V. Basic Information
Table 141. Mylan N.V. Malaria Vaccines Product Overview
Table 142. Mylan N.V. Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Mylan N.V. Business Overview
Table 144. Mylan N.V. Recent Developments
Table 145. Zydus Cadila Basic Information
Table 146. Zydus Cadila Malaria Vaccines Product Overview
Table 147. Zydus Cadila Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Zydus Cadila Business Overview
Table 149. Zydus Cadila Recent Developments
Table 150. Cipla Inc Basic Information
Table 151. Cipla Inc Malaria Vaccines Product Overview
Table 152. Cipla Inc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Cipla Inc Business Overview
Table 154. Cipla Inc Recent Developments
Table 155. Sun Pharmaceutical Industries Ltd Basic Information
Table 156. Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Overview
Table 157. Sun Pharmaceutical Industries Ltd Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Sun Pharmaceutical Industries Ltd Business Overview
Table 159. Sun Pharmaceutical Industries Ltd Recent Developments
Table 160. Sanofi Basic Information
Table 161. Sanofi Malaria Vaccines Product Overview
Table 162. Sanofi Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Sanofi Business Overview
Table 164. Sanofi Recent Developments
Table 165. Hikma Pharmaceuticals PLC Basic Information
Table 166. Hikma Pharmaceuticals PLC Malaria Vaccines Product Overview
Table 167. Hikma Pharmaceuticals PLC Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Hikma Pharmaceuticals PLC Business Overview
Table 169. Hikma Pharmaceuticals PLC Recent Developments
Table 170. Amneal Pharmaceuticals LLC Basic Information
Table 171. Amneal Pharmaceuticals LLC Malaria Vaccines Product Overview
Table 172. Amneal Pharmaceuticals LLC Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Amneal Pharmaceuticals LLC Business Overview
Table 174. Amneal Pharmaceuticals LLC Recent Developments
Table 175. Taj Pharmaceuticals Limited Basic Information
Table 176. Taj Pharmaceuticals Limited Malaria Vaccines Product Overview
Table 177. Taj Pharmaceuticals Limited Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Taj Pharmaceuticals Limited Business Overview
Table 179. Taj Pharmaceuticals Limited Recent Developments
Table 180. Lupin Basic Information
Table 181. Lupin Malaria Vaccines Product Overview
Table 182. Lupin Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. Lupin Business Overview
Table 184. Lupin Recent Developments
Table 185. Novartis AG Basic Information
Table 186. Novartis AG Malaria Vaccines Product Overview
Table 187. Novartis AG Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Novartis AG Business Overview
Table 189. Novartis AG Recent Developments
Table 190. CellFree Sciences Basic Information
Table 191. CellFree Sciences Malaria Vaccines Product Overview
Table 192. CellFree Sciences Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 193. CellFree Sciences Business Overview
Table 194. CellFree Sciences Recent Developments
Table 195. Global Malaria Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 196. Global Malaria Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 197. North America Malaria Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 198. North America Malaria Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 199. Europe Malaria Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 200. Europe Malaria Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 201. Asia Pacific Malaria Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 202. Asia Pacific Malaria Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 203. South America Malaria Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 204. South America Malaria Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 205. Middle East and Africa Malaria Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 206. Middle East and Africa Malaria Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 207. Global Malaria Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 208. Global Malaria Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 209. Global Malaria Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 210. Global Malaria Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 211. Global Malaria Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Malaria Vaccines Market Size by Type (M USD)
Table 4. Global Malaria Vaccines Market Size by Application
Table 5. Malaria Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Malaria Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Malaria Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Malaria Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Malaria Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2025)
Table 11. Global Market Malaria Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Malaria Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Malaria Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Malaria Vaccines Sales by Type (K MT)
Table 27. Global Malaria Vaccines Market Size by Type (M USD)
Table 28. Global Malaria Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Malaria Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Malaria Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Malaria Vaccines Market Share by Type (2020-2025)
Table 32. Global Malaria Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Malaria Vaccines Sales (K MT) by Application
Table 34. Global Malaria Vaccines Market Size by Application
Table 35. Global Malaria Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Malaria Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Malaria Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Malaria Vaccines Market Share by Application (2020-2025)
Table 39. Global Malaria Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Malaria Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Malaria Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Malaria Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Malaria Vaccines Market Size by Region (2020-2025)
Table 44. North America Malaria Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Malaria Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Malaria Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Malaria Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Malaria Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Malaria Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Malaria Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Malaria Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Malaria Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Malaria Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Malaria Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Malaria Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Malaria Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Malaria Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GlaxoSmithKline Plc Basic Information
Table 63. GlaxoSmithKline Plc Malaria Vaccines Product Overview
Table 64. GlaxoSmithKline Plc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GlaxoSmithKline Plc Business Overview
Table 66. GlaxoSmithKline Plc SWOT Analysis
Table 67. GlaxoSmithKline Plc Recent Developments
Table 68. Sanaria Inc Basic Information
Table 69. Sanaria Inc Malaria Vaccines Product Overview
Table 70. Sanaria Inc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Sanaria Inc Business Overview
Table 72. Sanaria Inc SWOT Analysis
Table 73. Sanaria Inc Recent Developments
Table 74. Nobelpharma Co Basic Information
Table 75. Nobelpharma Co Malaria Vaccines Product Overview
Table 76. Nobelpharma Co Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Nobelpharma Co Business Overview
Table 78. Nobelpharma Co SWOT Analysis
Table 79. Nobelpharma Co Recent Developments
Table 80. Sumaya Biotech Basic Information
Table 81. Sumaya Biotech Malaria Vaccines Product Overview
Table 82. Sumaya Biotech Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sumaya Biotech Business Overview
Table 84. Sumaya Biotech Recent Developments
Table 85. GenVec Basic Information
Table 86. GenVec Malaria Vaccines Product Overview
Table 87. GenVec Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. GenVec Business Overview
Table 89. GenVec Recent Developments
Table 90. Actiza Pharmaceutical Private Limited Basic Information
Table 91. Actiza Pharmaceutical Private Limited Malaria Vaccines Product Overview
Table 92. Actiza Pharmaceutical Private Limited Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Actiza Pharmaceutical Private Limited Business Overview
Table 94. Actiza Pharmaceutical Private Limited Recent Developments
Table 95. AdvaCare Pharma Basic Information
Table 96. AdvaCare Pharma Malaria Vaccines Product Overview
Table 97. AdvaCare Pharma Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. AdvaCare Pharma Business Overview
Table 99. AdvaCare Pharma Recent Developments
Table 100. Ipca Laboratories Ltd Basic Information
Table 101. Ipca Laboratories Ltd Malaria Vaccines Product Overview
Table 102. Ipca Laboratories Ltd Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Ipca Laboratories Ltd Business Overview
Table 104. Ipca Laboratories Ltd Recent Developments
Table 105. Bliss GVS Pharma Ltd Basic Information
Table 106. Bliss GVS Pharma Ltd Malaria Vaccines Product Overview
Table 107. Bliss GVS Pharma Ltd Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Bliss GVS Pharma Ltd Business Overview
Table 109. Bliss GVS Pharma Ltd Recent Developments
Table 110. GeoVax Basic Information
Table 111. GeoVax Malaria Vaccines Product Overview
Table 112. GeoVax Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. GeoVax Business Overview
Table 114. GeoVax Recent Developments
Table 115. Pfizer Inc Basic Information
Table 116. Pfizer Inc Malaria Vaccines Product Overview
Table 117. Pfizer Inc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Pfizer Inc Business Overview
Table 119. Pfizer Inc Recent Developments
Table 120. VLP Therapeutics Basic Information
Table 121. VLP Therapeutics Malaria Vaccines Product Overview
Table 122. VLP Therapeutics Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. VLP Therapeutics Business Overview
Table 124. VLP Therapeutics Recent Developments
Table 125. OSIVAX Basic Information
Table 126. OSIVAX Malaria Vaccines Product Overview
Table 127. OSIVAX Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. OSIVAX Business Overview
Table 129. OSIVAX Recent Developments
Table 130. AJANTA PHARMA Basic Information
Table 131. AJANTA PHARMA Malaria Vaccines Product Overview
Table 132. AJANTA PHARMA Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. AJANTA PHARMA Business Overview
Table 134. AJANTA PHARMA Recent Developments
Table 135. Strides Pharma Science Limited Basic Information
Table 136. Strides Pharma Science Limited Malaria Vaccines Product Overview
Table 137. Strides Pharma Science Limited Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Strides Pharma Science Limited Business Overview
Table 139. Strides Pharma Science Limited Recent Developments
Table 140. Mylan N.V. Basic Information
Table 141. Mylan N.V. Malaria Vaccines Product Overview
Table 142. Mylan N.V. Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Mylan N.V. Business Overview
Table 144. Mylan N.V. Recent Developments
Table 145. Zydus Cadila Basic Information
Table 146. Zydus Cadila Malaria Vaccines Product Overview
Table 147. Zydus Cadila Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Zydus Cadila Business Overview
Table 149. Zydus Cadila Recent Developments
Table 150. Cipla Inc Basic Information
Table 151. Cipla Inc Malaria Vaccines Product Overview
Table 152. Cipla Inc Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Cipla Inc Business Overview
Table 154. Cipla Inc Recent Developments
Table 155. Sun Pharmaceutical Industries Ltd Basic Information
Table 156. Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Overview
Table 157. Sun Pharmaceutical Industries Ltd Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Sun Pharmaceutical Industries Ltd Business Overview
Table 159. Sun Pharmaceutical Industries Ltd Recent Developments
Table 160. Sanofi Basic Information
Table 161. Sanofi Malaria Vaccines Product Overview
Table 162. Sanofi Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Sanofi Business Overview
Table 164. Sanofi Recent Developments
Table 165. Hikma Pharmaceuticals PLC Basic Information
Table 166. Hikma Pharmaceuticals PLC Malaria Vaccines Product Overview
Table 167. Hikma Pharmaceuticals PLC Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Hikma Pharmaceuticals PLC Business Overview
Table 169. Hikma Pharmaceuticals PLC Recent Developments
Table 170. Amneal Pharmaceuticals LLC Basic Information
Table 171. Amneal Pharmaceuticals LLC Malaria Vaccines Product Overview
Table 172. Amneal Pharmaceuticals LLC Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Amneal Pharmaceuticals LLC Business Overview
Table 174. Amneal Pharmaceuticals LLC Recent Developments
Table 175. Taj Pharmaceuticals Limited Basic Information
Table 176. Taj Pharmaceuticals Limited Malaria Vaccines Product Overview
Table 177. Taj Pharmaceuticals Limited Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Taj Pharmaceuticals Limited Business Overview
Table 179. Taj Pharmaceuticals Limited Recent Developments
Table 180. Lupin Basic Information
Table 181. Lupin Malaria Vaccines Product Overview
Table 182. Lupin Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. Lupin Business Overview
Table 184. Lupin Recent Developments
Table 185. Novartis AG Basic Information
Table 186. Novartis AG Malaria Vaccines Product Overview
Table 187. Novartis AG Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Novartis AG Business Overview
Table 189. Novartis AG Recent Developments
Table 190. CellFree Sciences Basic Information
Table 191. CellFree Sciences Malaria Vaccines Product Overview
Table 192. CellFree Sciences Malaria Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 193. CellFree Sciences Business Overview
Table 194. CellFree Sciences Recent Developments
Table 195. Global Malaria Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 196. Global Malaria Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 197. North America Malaria Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 198. North America Malaria Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 199. Europe Malaria Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 200. Europe Malaria Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 201. Asia Pacific Malaria Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 202. Asia Pacific Malaria Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 203. South America Malaria Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 204. South America Malaria Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 205. Middle East and Africa Malaria Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 206. Middle East and Africa Malaria Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 207. Global Malaria Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 208. Global Malaria Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 209. Global Malaria Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 210. Global Malaria Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 211. Global Malaria Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Malaria Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Malaria Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Malaria Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Malaria Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Malaria Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Malaria Vaccines Product Life Cycle
Figure 13. Malaria Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Malaria Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Malaria Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Malaria Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Malaria Vaccines
Figure 19. Global Malaria Vaccines Market PEST Analysis
Figure 20. Global Malaria Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Malaria Vaccines Market Share by Type
Figure 27. Sales Market Share of Malaria Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Malaria Vaccines by Type in 2025
Figure 29. Market Share of Malaria Vaccines by Type (2020-2025)
Figure 30. Market Share of Malaria Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Malaria Vaccines Market Share by Application
Figure 33. Global Malaria Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Malaria Vaccines Sales Market Share by Application in 2025
Figure 35. Global Malaria Vaccines Market Share by Application (2020-2025)
Figure 36. Global Malaria Vaccines Market Share by Application in 2025
Figure 37. Global Malaria Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Malaria Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Malaria Vaccines Market Size by Region (2020-2025)
Figure 40. North America Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Malaria Vaccines Sales Market Share by Country in 2024
Figure 43. North America Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Malaria Vaccines Market Size by Country in 2024
Figure 45. U.S. Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Malaria Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Malaria Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Malaria Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Malaria Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Malaria Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Malaria Vaccines Market Size by Country in 2024
Figure 55. Germany Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Malaria Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Malaria Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Malaria Vaccines Market Size by Region in 2024
Figure 68. China Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Malaria Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Malaria Vaccines Sales Market Share by Country in 2024
Figure 80. South America Malaria Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Malaria Vaccines Market Size by Country in 2024
Figure 82. Brazil Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Malaria Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Malaria Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Malaria Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Malaria Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Malaria Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Malaria Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Malaria Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Malaria Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Malaria Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Malaria Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Malaria Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Malaria Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Malaria Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Malaria Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Malaria Vaccines Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Malaria Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Malaria Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Malaria Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Malaria Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Malaria Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Malaria Vaccines Product Life Cycle
Figure 13. Malaria Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Malaria Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Malaria Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Malaria Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Malaria Vaccines
Figure 19. Global Malaria Vaccines Market PEST Analysis
Figure 20. Global Malaria Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Malaria Vaccines Market Share by Type
Figure 27. Sales Market Share of Malaria Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Malaria Vaccines by Type in 2025
Figure 29. Market Share of Malaria Vaccines by Type (2020-2025)
Figure 30. Market Share of Malaria Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Malaria Vaccines Market Share by Application
Figure 33. Global Malaria Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Malaria Vaccines Sales Market Share by Application in 2025
Figure 35. Global Malaria Vaccines Market Share by Application (2020-2025)
Figure 36. Global Malaria Vaccines Market Share by Application in 2025
Figure 37. Global Malaria Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Malaria Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Malaria Vaccines Market Size by Region (2020-2025)
Figure 40. North America Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Malaria Vaccines Sales Market Share by Country in 2024
Figure 43. North America Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Malaria Vaccines Market Size by Country in 2024
Figure 45. U.S. Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Malaria Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Malaria Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Malaria Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Malaria Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Malaria Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Malaria Vaccines Market Size by Country in 2024
Figure 55. Germany Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Malaria Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Malaria Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Malaria Vaccines Market Size by Region in 2024
Figure 68. China Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Malaria Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Malaria Vaccines Sales Market Share by Country in 2024
Figure 80. South America Malaria Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Malaria Vaccines Market Size by Country in 2024
Figure 82. Brazil Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Malaria Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Malaria Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Malaria Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Malaria Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Malaria Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Malaria Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Malaria Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Malaria Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Malaria Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Malaria Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Malaria Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Malaria Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Malaria Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Malaria Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Malaria Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Malaria Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Malaria Vaccines Market Share Forecast by Application (2026-2035)
